pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,783 catalysts · 6,459 phase readout · 2,318 8k filing · 388 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 0 catalysts2026-08-19: 7 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,459
  • 8k filing2,318
  • earnings388
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

33
›ACTIVE_NOT_RECRUITINGphase readoutNCT05864560: Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.. Phase: . Conditions: Abdominal Aortic Aneurysm

full page →ctgov ↗
›TERMINATEDphase readoutNCT03996460: K0706 for Patients Diagnosed With Dementia With Lewy Bodies

Sponsor: Georgetown University. Phase: PHASE2. Conditions: Dementia With Lewy Bodies

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07249320: Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants

Sponsor: Pfizer. Phase: . Conditions: Respiratory Syncytial Virus (RSV)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06715020: Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging

Sponsor: Peking University Cancer Hospital & Institute. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT04055220: Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Sponsor: Centre Leon Berard. Phase: NA. Conditions: Bone Sarcoma, Osteosarcoma, Ewing Sarcoma, Chondrosarcoma, Undifferentiated Pleomorphic Sarcoma, Leiomyosarcoma, Angiosarcoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07653620: Hydration & Female Life Stages

Sponsor: PepsiCo Global R&D. Phase: NA. Conditions: Dehydration, Menstruation, Pre-menopause, Peri-menopausal Women, Post-menopausal Women, Hydration

full page →ctgov ↗
›COMPLETEDphase readoutNCT06516120: Kinematics of Movements Provoked by an Augmented Reality App

Sponsor: Sint Maartenskliniek. Phase: . Conditions: Stroke, Healthy Aging

full page →ctgov ↗
›RECRUITINGphase readoutNCT05254782: Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection

Sponsor: University Health Network, Toronto. Phase: . Conditions: Non Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05133882: A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML

Sponsor: Sunshine Lake Pharma Co., Ltd.. Phase: PHASE1. Conditions: Acute Myeloid Leukemia, Adult

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07639710: Effect of Progressive Muscle Relaxation and Diaphragmatic Breathing on Sleep Disturbances in Chemotherapy Patients

Sponsor: Cairo University. Phase: NA. Conditions: Sleep Disturbance, Sleep Disorders, Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05995613: Evaluation of MABOS for Improved Pulse Oximeter Accuracy in Patients of Color

Sponsor: University of North Carolina, Chapel Hill. Phase: . Conditions: Oxygen Saturation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06414460: Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

Sponsor: InSilico Medicine Hong Kong Limited. Phase: PHASE1. Conditions: Locally Advanced/Metastatic Solid Tumors

full page →ctgov ↗
›COMPLETEDphase readoutNCT07123220: Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus

Sponsor: Investigación en Hemofilia y Fisioterapia. Phase: . Conditions: Lupus Erythematosus, Systemic

full page →ctgov ↗
›RECRUITINGphase readoutNCT07245082: Patients With Type 2 Diabetes

Sponsor: National Taiwan University Hospital. Phase: . Conditions: Diabetes Mellitus Type 2

full page →ctgov ↗
›COMPLETEDphase readoutNCT07696013: The Effect of Personalized Nutrition on Changes in Metabolic Parameters in Patients With Type 2 Diabetes Mellitus

Sponsor: DINA KEUMALA SARI. Phase: NA. Conditions: Type 2 Diabetes

full page →ctgov ↗
›RECRUITINGphase readoutNCT06054360: Predictive Value of Right Atrial Strain in Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Postoperative Atrial Fibrillation, Strains

full page →ctgov ↗
›RECRUITINGphase readoutNCT07748520: Effect of Nesting During Intramuscular Injection on Pain, Stress, and Breastfeeding Success in Cesarean-Born Term Newborns

Sponsor: Istanbul University - Cerrahpasa. Phase: NA. Conditions: Newborn Pain, Newborn Stress, Breastfeeding Success in Newborns

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03540420: Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

Sponsor: Norwegian University of Science and Technology. Phase: PHASE2. Conditions: Small-cell Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07752082: The Impact of Intra-Abdominal Pressure on Mortality and Morbidity in Patients Undergoing Open-Heart Surgery

Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital. Phase: . Conditions: Intra-Abdominal Hypertension, Postoperative Complications

full page →ctgov ↗
›RECRUITINGphase readoutNCT07615582: Clinical Performance and Multitasking in Anesthesia : a Simulation-based Study

Sponsor: University Hospital, Grenoble. Phase: . Conditions: Multitasking Behavior and Multitasking Ability, Clinical Performance, Simulation Training, Simulation Based Medical Education, Clinical Reasoning, Anesthesia

full page →ctgov ↗
›SUSPENDEDphase readoutNCT03220282: The Milk, Growth and Microbiota Study

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Preterm Infant, Growth Delay, Microbial Colonization, Breastfeeding, Breast Milk Substitute Intolerance

full page →ctgov ↗
›RECRUITINGphase readoutNCT04002882: Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)

Sponsor: Emory University. Phase: . Conditions: Cystic Fibrosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07724782: Multi-Cohort Study of Zeprumetostat Combinations for Relapsed/Refractory PTCL

Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE1. Conditions: PTCL-NOS

full page →ctgov ↗
›COMPLETEDphase readoutNCT03392324: PRIMA US-Feasibility Study in Atrophic Dry AMD

Sponsor: Science Corporation. Phase: NA. Conditions: Dry Age-related Macular Degeneration

full page →ctgov ↗
›RECRUITINGphase readoutNCT06306924: UNC Metastatic Cancer Radiation Therapy Registry

Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: . Conditions: Cancer, Metastatic Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07699523: The Effects of Midazolam, Dexmedetomidine, and Esketamine on Bispectral Index and Raw Electroencephalogram in Patients Under Propofol-Remifentanil Baseline Anesthesia

Sponsor: China-Japan Friendship Hospital. Phase: NA. Conditions: Depth of Anesthesia Monitoring, BIS-EEG

full page →ctgov ↗
›COMPLETEDphase readoutNCT07723859: Child Sexual Abuse Prevention Education for Primary School Children

Sponsor: Tokat Gaziosmanpasa University. Phase: NA. Conditions: Second-grade Primary School Students

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07623759: Early Diagnostic Telehealth Pilot for Moderate- and High-Risk Children: Evaluating Assessment Protocols and Efficiency in Georgia's Early Intervention Program

Sponsor: Emory University. Phase: NA. Conditions: Autism Spectrum Disorder, Autism

full page →ctgov ↗
›RECRUITINGphase readoutNCT07385196: Defining Ileorectal Syndrome: a Prospective Observational Study

Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital. Phase: . Conditions: Total Colectomy, Diarrhea, Urgency Incontinence, Soilings, Fecal

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04590235: A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Neurofibromatosis 1, Neurofibroma Plexiform

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03473743: A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Urothelial Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05206617: 3 Year Follow up on ANO5 Patients

Sponsor: Rigshospitalet, Denmark. Phase: . Conditions: Neuromuscular Diseases, Limb Girdle Muscular Dystrophy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03104517: Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

Sponsor: Cook MyoSite. Phase: PHASE3. Conditions: Stress Urinary Incontinence

full page →ctgov ↗
← prev
page 176 of 176
next →